Tasly Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.taslyus.com
A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05188274
- Locations
- 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States
Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05183594
- Locations
- 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States
Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
- Conditions
- Interventions
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 853
- Registration Number
- NCT04993729
- Locations
- 🇺🇸
Hypoxia Research Lab, UCSF Parnassus Campus, S-256, San Francisco, California, United States
🇨🇳Affiliated Hospital of Chengdu University of TCM, Chengdu, Sichuan, China
🇨🇳Tibet Autonomous Region People's Hospital, Lhasa, Tibet, China
Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
- Conditions
- First Posted Date
- 2020-11-27
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Registration Number
- NCT04646031
- Locations
- 🇺🇸
MultiCare Health System, Tacoma, Washington, United States
The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-02-26
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Registration Number
- NCT04285190
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
- First Posted Date
- 2018-12-28
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 765
- Registration Number
- NCT03789552
- Locations
- 🇺🇸
Southwest Florida Research LLC, Naples, Florida, United States
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT03613688
- Locations
- 🇺🇸
NIS labs, Klamath Falls, Oregon, United States
Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
- Conditions
- Interventions
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT03552263
- Locations
- 🇺🇸
Hypoxia Research Lab, UCSF Parnassus Campus, S-256, San Francisco, California, United States
Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness
- Conditions
- Interventions
- First Posted Date
- 2017-09-01
- Last Posted Date
- 2017-09-01
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT03270787
- Locations
- 🇨🇳
People's Hospital of Tibet Autonomous Region, Damxung, Tibet, China
A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2016-03-21
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Tasly Pharmaceuticals, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT02714608
- Locations
- 🇨🇳
Jing'an District Centre Hospital of Shanghai, Shang Hai, Shanghai, China
🇨🇳Guangdong Provincial Hospital of TCM, Guang Zhou, Guangdong, China
🇨🇳Jiangsu Provincial Hospital of Integrated Chinese Traditional and Western Medicine, Nan Jing, Jiangsu, China